Kathy Song

Kathy Song serves as a procurement professional within the National Institute of Allergy and Infectious Diseases (NIAID), supporting the agency’s mission to accelerate biomedical research responses to infectious, immunologic, and allergic threats. She manages complex acquisitions for high-containment laboratory infrastructure, analytical instrumentation, and specialized diagnostic technologies critical to public health preparedness. Her work ensures the timely deployment of scientific capabilities across biosafety level 3 and 4 facilities, with a focus on procurement strategies that align with federal research priorities and regulatory compliance standards. Her primary contractor relationships include Quality Biological, Inc., a key provider of biological reference materials and viral reagents, and Genomic Labs Ltd., which supports advanced genomic sequencing and molecular diagnostics. These partnerships reflect a reliance on specialized vendors with deep technical expertise in biosafety-critical supplies and high-complexity laboratory systems. Song’s contracting approach emphasizes vendor reliability, regulatory adherence, and supply chain resilience, particularly for materials requiring stringent biospecimen handling and cold-chain logistics. Her procurement portfolio reflects a strong preference for open competition, with 87.5% of awards issued without set-asides, indicating a focus on technical merit and specialized capability over socioeconomic classifications. Nevertheless, she consistently allocates 12.5% of opportunities to total small business set-asides under FAR 19.5, demonstrating a measured commitment to small business participation without compromising mission-critical requirements. Kathy’s acquisitions are heavily concentrated in NAICS 334516 (analytical laboratory instrument manufacturing) and 811210 (electronic and precision equipment repair and maintenance), underscoring her expertise in procuring mass spectrometers, PCR platforms, biosafety cabinets, and high-precision diagnostic systems. She also supports institutional research capacity through collaborations with academic institutions under NAICS 611310, ensuring that NIAID’s laboratory infrastructure remains at the forefront of infectious disease research and response.